Collplant announces development and global commercialization agreement with allergan aesthetics, an abbvie company, for rhcollagen in dermal and soft tissue filler products

Rehovot, israel, feb. 8, 2021 /prnewswire/ -- collplant biotechnologies (nasdaq: clgn) today announced it has entered into a worldwide exclusive development and commercialization agreement for dermal and soft tissue filler products with allergan aesthetics, an abbvie company. collplant...

CLGN Ratings Summary

CLGN Quant Ranking